Tenax Therapeutics (TENX) EBIT Margin (2010 - 2015)

Tenax Therapeutics has disclosed EBIT Margin across 5 years of filings, most recently posting 9874.97% for Q2 2015.

• In Q2 2015, EBIT Margin changed N/A year-over-year to 9874.97%; the TTM figure through Jun 2016 stood at 29548.27% (down 2868261.0% YoY), while the FY2015 annual figure was 33603.73%, changed N/A from the prior year.
• EBIT Margin came in at 9874.97% for Q2 2015 at Tenax Therapeutics, down from 682.51% in the prior quarter.
• In the past five years, EBIT Margin ranged from a high of 10360.51% in Q1 2011 to a low of 9874.97% in Q2 2015.
• Average EBIT Margin over 4 years is 967.77%, with a median of 715.64% recorded in 2013.
• The largest YoY upside for EBIT Margin was 914614 bps in 2012 against a maximum downside of 1162433 bps in 2012.
• Over 4 years, EBIT Margin stood at 2158.73% in 2011, then surged by 94 bps to 132.62% in 2012, then tumbled by 415 bps to 682.51% in 2013, then sank by 1347 bps to 9874.97% in 2015.
• Per Business Quant data, the three most recent EBIT Margin figures were 9874.97% in Q2 2015, 682.51% in Q2 2013, and 715.64% in Q1 2013.